HitIQ Limited

HitIQ Limited (ASX:HIQ)

Offer Price

A$0.0220

per share

Offer Size

A$680,000

Open Now!
Apply Now

Placement

HitIQ Limited (ASX:HIQ)

HIQ

Lead Manager

Offer Price

A$0.0220

per share

Offer Size

A$680,000

Placement

HitIQ Limited

Offer Details

Issue Price (Per Share)

A$0.0220

Discount

-4.76%

Offer Size

A$680,000

Shares Available

30,909,090

A private placement to raise approximately $680,000 (30,909,091 securities), with the ability to take oversubscriptions. The placement shares have a 1 for 2 free attaching option, with an exercise price of $0.022 and an expiry date of 30 December 2028. The options are to be ASX listed.

Sub-underwriting offer :

  • The company will conduct a non-renounceable entitlement offer on a 1 for 3 basis to raise up to $2,914,791 (132,490,514 shares)
  • The entitlement offer is on the same terms as the placement offer, an issue price of $0.022 per share, with 1 for 2 free attaching option (Exercisable at $0.022, expiring 30th Dec 28). The options are to be ASX listed.
  • GBA Capital Pty Ltd will underwrite the entitlement offer up to the amount of sub-underwriting commitments.
  • Sub-underwriters will receive a sub-underwriting fee of 1.5% of the amount sub-underwriting and 4 sub-underwriter options per $1 sub-underwritten. Sub-underwriter options are on the same terms as the placement and entitlement offer options. For example, a $100,000 sub-underwriting allocation would receive $1,500 fee and 400,000 sub-underwriter options.

Joint Lead Mangers: SP Corporate Advisory & GBA Capital

Company Overview

HITIQ Limited (ASX: HIQ) is a sports technology company developing smart mouthguard systems that monitor and manage concussion risk. Following a successful track record in elite sports, the company is now targeting the vastly larger amateur and community sports market, unlocking significant scale and recurring revenue potential.

Product - PROTEQT

The company’s flagship product, PROTEQT, is a first-to-market consumer solution: a smart, boil-and-bite mouthguard paired with a mobile app that delivers real-time head impact detection, symptom assessment, and telehealth access. The technology is backed by validation from Virginia Tech and Monash University, approved under World Rugby standards, and protected by a granted U.S. patent.

PROTEQT is designed for widespread adoption across youth and community-level sports. The product is delivered via a subscription model, with annual renewals covering both mouthguard replacement and continued software access. A three-year partnership with the Victorian Amateur Football Association (VAFA) marks the launchpad for national rollout, supported by strong early interest from athletes, clubs, and parents.

Addressable Market & Growth Strategy

HITIQ is strategically expanding into key markets with significant opportunities:

  • Australia (FY26): Targeting approximately 1 million amateur collision sports players, representing a Year 1 Total Addressable Market (TAM) of AU$349 million, followed by recurring subscription revenue.
  • United Kingdom (FY26): Aiming to reach around 5 million grassroots collision sports participants, equating to a Year 1 TAM of AU$1.75 billion, with ongoing subscription-based revenue.
  • United States (FY27): Planning to enter the largest market with approximately 30 million youth and amateur collision sports players, contributing to a Year 1 TAM of AU$10.47 billion, with subsequent recurring subscription income.

The growth strategy is focused on a consumer-first rollout, beginning in Australia and scaling into the UK, EU, and US via an exclusive global distribution partnership with Shock Doctor. The SaaS-based business model is designed to scale efficiently, with high-margin upside driven by volume manufacturing, low incremental software costs, and strong user retention. A refreshed board and executive team with deep sports tech and commercialisation experience is leading the execution, supported by an infrastructure build-out to deliver the world’s largest concussion dataset to sporting bodies, healthcare providers, and government stakeholders.

Use of Funds

The funds raised will be focused towards:

Use of Funds

Application

1

Expansion of partnerships, marketing and sales activities in North America.

2

Enhance product lines to generate additional recurring revenue streams.

3

Invest in Business Development, marketing, CX and logistics.

4

Enhance data and AI capability for applications and continued CoVR studies.

5

General working capital.

Indicative Timetable

The below dates are indicative only and are subject to change without notice. The Company and the JLMs reserve the right to extend the Closing Date of the offer or close the capital raise early without notice. All times are in AEST (Sydney, Australia) unless stated otherwise.

Placement & Sub- Underwriting Offer Opens

Monday April 28 2025

Placement & Sub- Underwriting Offer Closes

Tuesday April 29 2025

Offer letters signed and accepted

5pm AEDT Tuesday April 29 2025

HIQ Recommences Trading

Wednesday April 30 2025

Placement Offer Tranche 1 Settlement Date (DVP)

Wednesday May 07 2025

Placement Offer Tranche 1 Allotment Date

Thursday May 08 2025

Entitlement Offer Opens (Estimate)

Early/Mid May 2025

Placement Offer Tranche 2 Settlement Date (DVP)

Early June 2025

Placement Offer Tranche 2 Allotment Date

Early June 2025

Entitlement Offer Closes (Estimate)

Early June 2025

Notice of Meeting (Broker Options and $1.6m of Convertible Note conversion)

Mid/Late June 2025

Sub-Underwriter Shortfall (Estimate)

Late June 2025

Sub-Underwriter Funds due (Estimate)

Late June 2025

Board & Management

Earl Eddings

Earl Eddings

Executive Chairman

Earl brings extensive leadership experience as the former Chair of Cricket Australia and Director of the International Cricket Council. He currently serves as a Non-Executive Director of sports tech company MSL Solutions and holds various governance and risk management credentials.

Jennifer Tucker

Jennifer Tucker

Non-Executive Director

Jennifer is a seasoned executive with expertise in consumer products and health sectors, having previously held leadership roles at Yates (DuluxGroup), Bunnings, and Bunnings Warehouse. She also serves as a Non-Executive Director of the National Heart Foundation, CAD Frontiers, and Cranky Health.

Phil Carulli

Phil Carulli

Non-Executive Director

Phil is a Chartered Accountant and the Managing Director or Optima Partners. He has been a Non-Executive Director and CFO of HITIQ since August 2018 and also holds a Non-Executive Director role at Soar-Earth Limited.

Matthew Clayworth

Matthew Clayworth

Non-Executive Director

Matthew is a Senior Investment Advisor at Wilson’s Advisory and represents Harmil Angel Investments. He previously held the role of Vice President at Morgan Stanley, bringing a wealth of financial and investment expertise to HITIQ.

James Barrie

James Barrie

Non-Executive Director

James is a professional Company Secretary and Non-Executive Director with experience across ASX20, ASX100, and microcap companies. He is also the Founder of Fernville Group and has held senior executive roles in governance and corporate strategy.

Disclaimer

This site does not constitute an offer, recommendation, or invitation to any person, nor does it purport to provide all of the information an interested party may require in order to investigate the affairs of HitIQ Limited. This site is provided for information only and has not been prepared with the intention that the recipient should rely on it. Liquidity Technology Pty Ltd ("Liquidity") does not make any representation in relation to the contents of this site or give any assurances as to the accuracy or the degree of care or diligence used in preparing this document. The information, data, and advice herein is provided to recipients on the clear understanding that Liquidity nor any of its representatives, directors, officers, employees, agents, or advisers makes any representation or warranty about its accuracy, reliability, completeness, or suitability for any particular purpose and does not accept liability (including, but not limited to, for any expenses, losses, damages, and/or costs (including, but not limited to, indirect or consequential damage)) nor take any responsibility of any kind whatsoever (including, but not limited to, whether in contract, tort, financial or otherwise) for the information, data, or advice contained in or for any omission or for any other information, statement, or representation provided to any recipient (including, but not limited to, as a result of information, data, or advice being inaccurate, unreliable, incomplete, or unsuitable in any way and for any reason whatsoever). Users of this site must conduct their own investigation and analysis regarding any information, statement, or representation contained or provided to any recipient or its associates by Liquidity or any of the Liquidity Personnel. Each recipient waives any right of action, which it has now or in the future against Liquidity or any of the Liquidity Personnel in respect of any errors or omissions on or from this site, however caused. All rights are reserved. If the whole or any part of a provision of this "Notice and Disclaimer" is invalid, illegal, or unenforceable, then such provision will be severed and neither that part or provision or its severance will affect the validity or enforceability of the remaining parts or provisions.

Disclosure of Interest: Liquidity receives commission from dealing in securities and its introducers of business may directly share in this commission. Liquidity and its associates may hold shares in HitIQ Limited.

HitIQ Limited

Placement

HitIQ Limited (ASX:HIQ)

HIQ

Offer Price

A$0.0220

per share

Offer Size

A$680,000

Cancel

I am a sophisticated 708 investor and agree to the terms and conditions

HitIQ Limited

Follow HitIQ Limited

By submitting your information below you can keep up to date with their relevant news and announcements.

Fields marked with * are required.

Name(Required)

Cancel

HitIQ Limited

Ask HitIQ Limited a question

Ask the company directors a question to understand more about their offering.

Fields marked with * are required.

Name(Required)

Cancel

HitIQ Limited

Submit your details below to get access to the product documents and invest.

Cancel